Merck's Man in the Hot Seat.

Examines pharmaceutical giant Merck and its CEO, Ray Gilmartin. Hopes of Gilmartin in new drugs; Calls for his firing before his planned retirement; Loss of Merck share value; Issues with Gilmartin's culture of scientific arrogance; Poor leadership decisions by Gilmartin; Concern over retaining top scientists; Likelihood that Gilmartin will not be forced out anytime soon.